Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
出版年份 2019 全文链接
标题
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
作者
关键词
Rheumatoid arthritis, HbA1c, Type 2 diabetes, Cytokines, Drug therapy, Inflammation, Insulin, Drug metabolism
出版物
PLOS MEDICINE
Volume 16, Issue 9, Pages e1002901
出版商
Public Library of Science (PLoS)
发表日期
2019-09-13
DOI
10.1371/journal.pmed.1002901
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis
- (2019) Siri Lillegraven et al. PLoS One
- Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis
- (2018) Shekoufeh Nikfar et al. RHEUMATOLOGY INTERNATIONAL
- Novel treatment strategies in rheumatoid arthritis
- (2017) Gerd R Burmester et al. LANCET
- Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis
- (2017) Piero Ruscitti et al. MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
- (2017) Piero Ruscitti et al. PLoS One
- Precision Medicine in Rheumatoid Arthritis
- (2017) James Bluett et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Multiple benefits of targeting inflammation in the treatment of type 2 diabetes
- (2016) Marc Y. Donath DIABETOLOGIA
- IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
- (2016) Roberto Giacomelli et al. Expert Review of Clinical Immunology
- Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
- (2015) P. Ruscitti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012
- (2015) Elizabeth Selvin et al. DIABETES CARE
- Head to Head Comparison of the Formulation and Stability of Concentrated Solutions of HESylated versus PEGylated Anakinra
- (2015) Robert Liebner et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Personalized medicine: Time for one-person trials
- (2015) Nicholas J. Schork NATURE
- Cardiovascular comorbidity in rheumatic diseases
- (2015) Michael T. Nurmohamed et al. Nature Reviews Rheumatology
- Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability
- (2015) Bart V. J. Cuppen et al. RHEUMATOLOGY
- Medication Therapy Management Interventions in Outpatient Settings
- (2015) Meera Viswanathan et al. JAMA Internal Medicine
- The Impact of Traditional Cardiovascular Risk Factors on Cardiovascular Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2015) Leena R. Baghdadi et al. PLoS One
- The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials
- (2014) Tzeyu L. Michaud et al. AMERICAN JOURNAL OF MEDICINE
- The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance
- (2014) P. C. M. van Poppel et al. DIABETES OBESITY & METABOLISM
- Targeting inflammation in the treatment of type 2 diabetes: time to start
- (2014) Marc Y. Donath NATURE REVIEWS DRUG DISCOVERY
- Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study
- (2014) Alper M. van Sijl et al. PLoS One
- Effect of Methotrexate Use and Erythrocyte Methotrexate Polyglutamate on Glycosylated Hemoglobin in Rheumatoid Arthritis
- (2014) Maurits C. F. J. de Rotte et al. Arthritis & Rheumatology
- EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
- (2013) N Duru et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial
- (2012) A. Rissanen et al. DIABETES OBESITY & METABOLISM
- Glucose tolerance, insulin sensitivity and -cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids
- (2011) J. N. Hoes et al. ANNALS OF THE RHEUMATIC DISEASES
- Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction
- (2011) Debby den Uyl et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-α therapy
- (2010) Miguel A. Gonzalez-Gay et al. Annals of the New York Academy of Sciences
- Stopping Randomized Trials Early for Benefit and Estimation of Treatment EffectsSystematic Review and Meta-regression Analysis
- (2010) Dirk Bassler JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
- (2009) Mike J. L. Peters et al. ARTHRITIS AND RHEUMATISM
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
- (2009) Kausik K Ray et al. LANCET
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now